Bufexamac

Confirm delete?

Bufexamac

Zoom

Cat No: 26068

Biochemicals - Small Molecule Inhibitors

Bufexamac is an NSAID and inhibitor of the class IIb histone deacetylases HDAC6 and HDAC10.{43497} It inhibits the production of IFN-α in peripheral blood mononuclear cells (PBMCs; EC50 = 8.9 µM). Bufexamac induces hyperacetylation of tubulin (IC50 = ...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

4-butoxy-N-hydroxy-benzeneacetamide

Correlated keywords:

Anderm CP 1044J3 Droxarol droxaryl Feximac Flogocid Malipuran Mofenar Norfemac Parfenac Parfenal Trolab HDAC-6 -10 IFN? H3-K5 5LO IL1?

Product Overview:
Bufexamac is an NSAID and inhibitor of the class IIb histone deacetylases HDAC6 and HDAC10.{43497} It inhibits the production of IFN-α in peripheral blood mononuclear cells (PBMCs; EC50 = 8.9 µM). Bufexamac induces hyperacetylation of tubulin (IC50 = 2.9 µM), a major substrate of HDAC6, without increasing acetylation of the class I HDAC substrates H3K5 or H3K9/K14. It also inhibits leukotriene A4 (LTA4) hydrolase and aminopeptidase activity (IC50s = 15.86 and 11.59 µM, respectively) and 5-lipoxygenase (5-LO) activity (IC50 = 27 µM).{43498,43499} Bufexamac inhibits the production of leukotriene B4 (LTB4; Item No. 20110) in neutrophils (IC50 = 12.91 µM) and reduces fMLP-induced neutrophil migration when used at concentrations of 50 and 100 µM.{43498} It also reduces neutrophil levels, as well as protein levels of TNF-α and IL-1β, in bronchoalveolar lavage fluid (BALF) in a mouse model of LPS-induced acute lung injury when administered at a dose of 100 mg/kg.

Size	25 mg
Shipping	wet ice
CAS Number	2438-72-4
Molecular Formula	C₁₂H₁₇NO₃
SMILES	CCCCOC1=CC=C(CC(NO)=O)C=C1
Molecular Weight	223,3
Formulation	A crystalline solid
Purity	≥98%
Custom Code	2924.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.